The nasal vaccine against COVID-19

iNCOVACC is a novel adenovirus vectored, intranasal vaccine for COVID-19. It has various advantages over injectable vaccines. Here are a few of them.

The two-drop nasal vaccine, iNCOVACC is manufactured by Bharat Biotech, India. It is a novel adenovirus vectored, intranasal vaccine for COVID-19 that can stimulate a broad immune response – neutralizing IgG, mucosal IgA, and T cell responses. 

How does it work?

The nasal vaccine is delivered through the nose or mouth. It is expected to work on the mucosal lining. Thus, the nasal vaccine prompts an immune response at the entry points of the virus which is mostly the nose and the mouth. This prevents infection at the entry point itself thereby protecting against disease, infection, and transmission. It is referred to as sterilizing immunity. Many studies have found that nasal delivery of vaccines is capable of creating a strong immune response.

Mice, Hamsters and macaques were immunized with a single dose of ChAd-SARS-CoV-2-S conferred superior protection against the SARS-CoV-2 challenge. Post-challenge with SARS-CoV-2, viral clearance was observed in both lower and upper airways in all these animal models.

Nasal vaccines v/s Injectable vaccines

Nasal vaccines have a proven benefit over injectable vaccines. In the third phase of the clinical trial which was done on 3,000 participants, iNCOVACC showed good immunity with 2 doses given 4 weeks apart.

Advantages of the nasal vaccine

  • An immune response at the site of infection is essential for blocking both infection and transmission of COVID-19.
  • Non-invasive, Needle-free
  • Ease of administration – does not require trained healthcare workers
  • Elimination of needle-associated risks (injuries and infections)
  • High compliance

Nasal vaccine composition

0.5 ml of this nasal vaccine contains NLT 5X10 particles per mL ChAd36-SARS-CoV-S COVID-19 virus (recombinant) including excipients such as Tris (pH 7.4), Sodium Chloride, Magnesium Chloride, Glycerol, Polysorbate- 80.

Those who have taken Covishield and Covaxin can take the nasal vaccine as a heterologous booster dose. In heterologous boosting, a person administered a different vaccine from the one that was used for the primary dose series.

The nasal vaccine as a booster dose and not the fourth dose after the booster shot

The nasal vaccine is recommended as a first booster and cannot be administered after one has taken the booster or the precautionary dose. This is because by repeatedly immunizing with a particular type of antigen, the body stops responding or responds poorly. Therefore, taking the nasal vaccine as the fourth dose after taking the booster dose is of no value.

Tags : #COVID19 #Nasalvaccine #Vaccination #VaccineforCOVID19 #iNCOVACC #MadeinIndiavaccine #NasalvaccineforCOVID19 #Medicircle #SmitaKumar

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

The Role of Hormones in Obesity: Why Men and Women Gain Weight DifferentlyJune 12, 2024
Silent Killer: How a Young Mother’s Vision Loss Led to a Lung Cancer DiagnosisJune 12, 2024
TruAlt Bioenergy’s subsidiary, Leafiniti Bioenergy supplies over 1000 tons of Compressed Biogas to AG&P Pratham in just 5 monthsJune 11, 2024
Southeast Asia's Most Advanced Luxury Postpartum Centre Re'Joy Suites Opens in SingaporeJune 11, 2024
Poor Muscle Health in Obesity Can be A Major Risk Factor for Early DeathJune 11, 2024
Machine Learning Uncovers How Organ Ageing Impacts Health and LongevityJune 11, 2024
Why Education is Essential for Health and LongevityJune 11, 2024
New Study Reveals Antidepressant Withdrawal Symptoms Less Common but Still SignificantJune 10, 2024
Why Lowering Salt Intake Might Help Your Skin: Key Findings from UCSF StudyJune 10, 2024
Exploring AI's Potential: I&B Ministry's Seminar on Jobs and Healthcare AdvancementsJune 10, 2024
Deeply saddened by the passing away of Sri Ramoji Rao GaruJune 08, 2024
Surmandal and Telangana Tourism to present Hindustani Classical recital at JNAFAUJune 08, 2024
Join CA Rahul Malodia in Rajkot for the ‘Vyapari to CEO’ Transformational WorkshopJune 08, 2024
Right diagnostic test and right treatment at the right time can prevent antimicrobial resistanceJune 08, 2024
Harnessing the Power of Yoga: I&B Ministry's Campaign for International Day of Yoga 2024June 08, 2024
Guarding Little Minds: Omega-3 Emulsion Shields Newborn BrainsJune 08, 2024
Laughter-Induced Syncope: When a Chuckle Turns SeriousJune 08, 2024
Latest Research Highlights The Role of Liver Glucose Production in Type 2 DiabetesJune 08, 2024
Ayushman Bharat Expansion: Bihar's Ambitious Health Card InitiativeJune 08, 2024
Nashik Hosts Successful ‘Frontiers In Onco-Surgery’ Conference At HCGMCC, Drawing Oncologists NationwideJune 07, 2024